Preoperative cholesterol levels do not predict explant for structural valve deterioration in patients undergoing bioprosthetic aortic valve replacement

Journal of Heart Valve Disease

Volumn 15, Issue 2, 2006, Pages 261-268

  Gring, Christian N ^a   Houghtaling, Penny ^a   Novaro, Gian M ^a   Roselli, Eric ^a   Smedira, Nicholas ^a   Banbury, Michael ^a   Blackstone, Eugene ^a   Griffin, Brian P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE; AGED; ANALYSIS OF VARIANCE; AORTA VALVE REPLACEMENT; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; COMPUTER PROGRAM; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DISEASE DURATION; DRUG USE; EXPLANT; FEMALE; FOLLOW UP; HEART VALVE BIOPROSTHESIS; HUMAN; HYPERCHOLESTEROLEMIA; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS FAILURE; RISK FACTOR; UNITED STATES; VALIDATION PROCESS;

AGED; AORTIC VALVE; BIOLOGICAL MARKERS; BIOPROSTHESIS; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33645575826     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000;36:1152-1158
2. Cohn LH, Collins JJ, Jr., DiSesa VJ, et al. Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements. Ann Surg 1989;210:435-442; discussion 442-443
3. Magilligan DJ, Jr., Lewis JW, Jr., Stein P, Alam M. The porcine bioprosthetic heart valve: Experience at 15 years. Ann Thorac Surg 1989;48:324-329; discussion 330
4. Edwards TJ, Livesey SA, Simpson IA, Monro JL, Ross JK. Biological valves beyond fifteen years: The Wessex experience. Ann Thorac Surg 1995;60:S211-S215
5. Jones EL, Weintraub WS, Craver JM, et al. Ten-year experience with the porcine bioprosthetic valve: Interrelationship of valve survival and patient survival in 1,050 valve replacements. Ann Thorac Surg 1990;49:370-383; discussion 383-384
6. Schoen FJ, Hobson CE. Anatomic analysis of removed prosthetic heart valves: Causes of failure of 33 mechanical valves and 58 bioprostheses, 1980 to 1983. Hum Pathol 1985;16:549-559
7. Grabenwoger M, Grimm M, Eybl E, et al. New aspects of the degeneration of bioprosthetic heart valves after long-term implantation. J Thorac Cardiovasc Surg 1992;104:14-21
8. Simionescu A, Simionescu D, Deac R. Biochemical pathways of tissue degeneration in bioprosthetic cardiac valves. The role of matrix metalloproteinases. Am Soc Artif Intern Organs J 1996;42:M561-M567
9. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90:844-853
10. Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001;88:693-695
11. Ngo MV, Gottdiener JS, Fletcher RD, Fernicola DJ, Gersh BJ. Smoking and obesity are associated with the progression of aortic stenosis. Am J Geriatr Cardiol 2001;10:86-90
12. Pohle K, Maffert R, Ropers D, et al. Progression of aortic valve calcification: Association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001;104:1927-1932
13. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002;40:1723-1730
14. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001;104:2205-2209
15. Antonini-Canterin F, Zuppiroli A, Popescu BA, et al. Effect of statins on the progression of bioprosthetic aortic valve degeneration. Am J Cardiol 2003;92:1479-1482
16. Farivar RS, Cohn LH. Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation. J Thorac Cardiovasc Surg 2003;126:969-975
17. Nollert G, Miksch J, Kreuzer E, Reichart B. Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement. J Thorac Cardiovasc Surg 2003;126:965-968
18. Yilmaz MB, Guray U, Guray Y, et al. Lipid profile of patients with aortic stenosis might be predictive of rate of progression. Am Heart J 2004;147:915-918
19. Blackstone EH, Naftel DC, Turner MEJ. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Statist Assoc 1986;81:615-624
20. Breiman L. Bagging predictors. Machine Learning 1996;24:123-140
21. Fann JI, Miller DC, Moore KA, et al. Twenty-year clinical experience with porcine bioprostheses. Ann Thorac Surg 1996;62:1301-1311; discussion 1311-1312
22. Akins CW, Hilgenberg AD, Vlahakes GJ, MacGillivray TE, Torchiana DF, Madsen JC. Results of bioprosthetic versus mechanical aortic valve replacement performed with concomitant coronary artery bypass grafting. Ann Thorac Surg 2002;74:1098-1106
23. Cohen G, David TE, Ivanov J, Armstrong S, Feindel CM. The impact of age, coronary artery disease, and cardiac comorbidity on late survival after bioprosthetic aortic valve replacement. J Thorac Cardiovasc Surg 1999;117:273-284
24. Angell WW, Pupello DF, Bessone LN, et al. Influence of coronary artery disease on structural deterioration of porcine bioprostheses. Ann Thorac Surg 1995;60:S276-S281
25. Schoen FJ, Levy RJ. Pathology of substitute heart valves: New concepts and developments. J Card Surg 1994;9:222-227